JAVIER
GANDASEGUI ARAHUETES
Investigador en el període 2020-2021
Leiden University Medical Center
Leiden, HolandaPublicacions en col·laboració amb investigadors/es de Leiden University Medical Center (7)
2022
-
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Gates Open Research, Vol. 6
-
Evaluation of antibody serology to determine current helminth and Plasmodium falciparum infections in a co-endemic area in Southern Mozambique
PLoS neglected tropical diseases, Vol. 16, Núm. 6, pp. e0010138
-
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347
-
Single-Nucleotide Polymorphisms in the Beta-Tubulin Gene and Its Relationship with Treatment Response to Albendazole in Human Soil-Transmitted Helminths in Southern Mozambique
American Journal of Tropical Medicine and Hygiene, Vol. 107, Núm. 3, pp. 649-657
2021
-
Improving stool sample processing and pyrosequencing for quantifying benzimidazole resistance alleles in Trichuris trichiura and Necator americanus pooled eggs
Parasites and Vectors, Vol. 14, Núm. 1
-
Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique
PLoS Neglected Tropical Diseases, Vol. 15, Núm. 10
2020
-
Role of DNA-detection–based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials
PLoS Neglected Tropical Diseases, Vol. 14, Núm. 2